Jefferies Highlights Presentation From Danaher at 2011 Global Healthcare Conference

According to a recent report from Jefferies, Danaher DHR presented at the 2011 Global Healthcare Conference hosted by Jefferies. The key highlights of the presentation touched on AB Sclex, the BEC Integration milestones and metric milestones, and the lack of deterioration in May trends. Jefferies maintains a Buy rating and $62.00 price target on the company. In the report, Jefferies said, "While DHR did not offer an official update on recent order and revenue trends, it appears to us that its trajectory has remained elevated through the end of May, and anecdotal commentary suggests its formal 2011 organic revenue growth outlook (+6 to +8%) remains highly relevant, in our view." Danaher closed yesterday at $51.94.